Advancing personalized health by leveraging deep analytics and proprietary technology to decode the epigenome ("the living genome").
The DNA sequence that makes up our genome is often referred to as the "hardware" of our body, as it is static and only provides specifications for the set of genes present, but not the instructions for how the hardware functions to turn genes "on" or "off".
Knowing the genetic sequence alone would be similar to buying a computer and knowing only the hardware specs, but not having knowledge about what operating systems it runs or the software available.

Connections from

Headquarters: United States
Investors Number: 9
Technology: Genetics/Genomics
Last Funding Type: Undisclosed
Funding Status: M&A
Employee Number: 11-50
Investment Stage: N/A
Number Of Exists: N/A
Investor Type: N/A
Founded Date: 2013
Industry: P4 Medicine